title: The impact of luteal phase support on endometrial estrogen and progesterone receptor expression: a randomized control trial.
abstract: BACKGROUND
  To assess the impact of luteal phase support on the expression of estrogen receptor (ER) alpha and progesterone receptors B (PR-B) on the endometrium of oocyte donors undergoing controlled ovarian hyperstimulation (COH).
  
  
  METHODS
  A prospective, randomized study was conducted in women undergoing controlled ovarian hyperstimulation for oocyte donation. Participants were randomized to receive no luteal support, vaginal progesterone alone, or vaginal progesterone plus orally administered 17 Beta estradiol. Endometrial biopsies were obtained at 4 time points in the luteal phase and evaluated by tissue microarray for expression of ER alpha and PR-B.
  
  
  RESULTS
  One-hundred and eight endometrial tissue samples were obtained from 12 patients. No differences were found in expression of ER alpha and PR-B among all the specimens with the exception of one sample value.
  
  
  CONCLUSIONS
  The administration of progesterone during the luteal phase of COH for oocyte donor cycles, either with or without estrogen, does not significantly affect the endometrial expression of ER alpha and PR.
authors.affiliation: Department of Gynecology and Obstetrics, Division of Reproductive Endocrinology and Infertility, Johns Hopkins University School of Medicine, 600 N, Wolfe Street, Baltimore, USA. pbrezin1@jhmi.edu
authors.forename: Paul R
authors.initials: PR
authors.lastname: Brezina
authors.forename: Nikos F
authors.initials: NF
authors.lastname: Vlahos
authors.forename: Tsung-Hsuan
authors.initials: TH
authors.lastname: Lai
authors.forename: Jairo E
authors.initials: JE
authors.lastname: Garcia
authors.forename: Edward E
authors.initials: EE
authors.lastname: Wallach
authors.forename: Yulian
authors.initials: Y
authors.lastname: Zhao
mesh_terms: D000328:Adult; D004958:Estradiol / Q000627:therapeutic use; D047628:Estrogen Receptor alpha / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D008183:Luteal Phase / Q000187:drug effects* / Q000502:physiology; D018587:Oocyte Donation / Q000379:methods*; D010062:Ovulation Induction / Q000379:methods; D011374:Progesterone / Q000627:therapeutic use; D011980:Receptors, Progesterone / Q000096:biosynthesis*
chemical_list: C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; D011980:Receptors, Progesterone; C097314:progesterone receptor B; D011374:Progesterone; D004958:Estradiol